Imiquimod

Green-G

Brand Name(s):Zyclara Aldara

Indication:Keratosis-nonhypertrophic, visible or palpable actinic of the full face or balding scalp in immunocompetent adults when other topical treatment options are contraindicated or less appropriate.

Rationale:

Considered:Jul-13

Review Date:Jun-23

Comments:
Aldara (Imiquimod 5% cream)
• Small SUPERFICIAL basal cell carcinomas (sBCCs) in adults.
• Clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (AKs) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and/or acceptability of cryotherapy and other topical treatment options are contraindicated or less appropriate. Zyclara (Imiquimod (3.75% cream)
• Clinically typical, nonhyperkeratotic, nonhypertrophic, visible or palpable actinic keratosis (AK) of the full face or balding scalp in immunocompetent adults when other topical treatment options are contraindicated or less appropriate.